The Role of Low Dose Whole Body CT in the Detection of Progression of Patients with Smoldering Multiple Myeloma - Top-Institutions - MDSpire

The Role of Low Dose Whole Body CT in the Detection of Progression of Patients with Smoldering Multiple Myeloma

  • By

  • Maria Gavriatopoulou

  • Andriani Βoultadaki

  • Vassilis Koutoulidis

  • Ioannis Ntanasis-Stathopoulos

  • Charis Bourgioti

  • Panagiotis Malandrakis

  • Despina Fotiou

  • Magdalini Migkou

  • Nikolaos Kanellias

  • Evangelos Eleutherakis-Papaiakovou

  • Efstathios Kastritis

  • Evangelos Terpos

  • Meletios A. Dimopoulos

  • Lia-Angela Moulopoulos

  • September 25, 2020

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology/Oncology
    • Radiology
    • Multiple Myeloma Research

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hematology/Oncology
    • Radiology
    • Plasma Cell Disorders

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematology/Oncology
    • Radiology
    • Myeloma Research

  • #4

    University of Arkansas for Medical Sciences (UAMS)
    University of Arkansas for Medical Sciences (UAMS)

    Little Rock, AR

    Key Differentiators

    • Hematology/Oncology
    • Multiple Myeloma Research

  • #5

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Hematology/Oncology
    • Radiology
    • Myeloma Research

Original Source(s)

The Role of Low Dose Whole Body CT in the Detection of Progression of Patients with Smoldering Multiple Myeloma

  • by Maria Gavriatopoulou, Andriani Βoultadaki, Vassilis Koutoulidis, Ioannis Ntanasis-Stathopoulos, Charis Bourgioti, Panagiotis Malandrakis, Despina Fotiou, Magdalini Migkou, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Efstathios Kastritis, Evangelos Terpos, Meletios A. Dimopoulos, Lia-Angela Moulopoulos

  • September 25, 2020

Related Content

Dana-Farber Research News 05.15.2026

This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from April 16 - 30.

  • by

  • May 15, 2026

  • 21 min
Using period analysis to timely provide serial data on long-term survival for patients with hematological malignancies from Taizhou, Eastern China

Case Report: Acute myeloid leukemia with mixed immunophenotypic features and TCF3::ZNF384 fusion in a pediatric patient with CNS involvement: a diagnostic and therapeutic challenge